Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

House ‘BioBond’ Bill Aims to Get Medical Research Back on Track

May 21, 2021, 1:30 PM

Biomedical companies and universities could jump-start clinical trials disrupted by the pandemic under a bipartisan House proposal to establish a new federally backed loan program.

Reps. Bobby L. Rush (D-Ill.) and Brian Fitzpatrick (R-Pa.) introduced legislation Friday that aims to boost “innovative biomedical research into therapies to address unmet medical needs,” according to a copy of the bill obtained in advance by Bloomberg Law. They modeled their proposal for “BioBonds” after green bonds, which are fixed-term loans to finance projects that will benefit the environment.

Companies and universities would be eligible for BioBonds under Rush’s proposal (H.R. 3437) if ...